California Public Employees Retirement System
ESPR

California Public Employees Retirement System’s Esperion Therapeutics ESPR Stock Holding History

California Public Employees Retirement System’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-52,800
Closed -$1.48M – 1993
2021
Q1 		$1.48M Hold
52,800
– – ﹤0.01% 2229
2020
Q4 		$1.37M Sell
52,800
-1,100
-2% -$33K ﹤0.01% 2257
2020
Q3 		$2M Sell
53,900
-3,315
-6% -$131K ﹤0.01% 1835
2020
Q2 		$2.94M Buy
57,215
+800
+1% +$33.5K ﹤0.01% 1555
2020
Q1 		$1.78M Sell
56,415
-300
-0.5% -$15.8K ﹤0.01% 1671
2019
Q4 		$3.38M Buy
56,715
+10,602
+23% +$477K ﹤0.01% 1715
2019
Q3 		$1.69M Buy
46,113
+14,066
+44% +$557K ﹤0.01% 1990
2019
Q2 		$1.49M Buy
32,047
+4,847
+18% +$228K ﹤0.01% 1897
2019
Q1 		$1.09M Sell
27,200
-700
-3% -$31.4K ﹤0.01% 2164
2018
Q4 		$1.28M Sell
27,900
-1,400
-5% -$67.5K ﹤0.01% 2030
2018
Q3 		$1.3M Sell
29,300
-5,178
-15% -$238K ﹤0.01% 2176
2018
Q2 		$1.35M Sell
34,478
-10,614
-24% -$536K ﹤0.01% 2158
2018
Q1 		$3.26M Sell
45,092
-3,766
-8% -$277K ﹤0.01% 1581
2017
Q4 		$3.22M Buy
48,858
+700
+1% +$37.7K ﹤0.01% 1654
2017
Q3 		$2.41M Buy
48,158
+6,258
+15% +$302K ﹤0.01% 1795
2017
Q2 		$1.94M Hold
41,900
– – ﹤0.01% 1890
2017
Q1 		$1.48M Sell
41,900
-1,900
-4% -$43.5K ﹤0.01% 2066
2016
Q4 		$548K Sell
43,800
-2,200
-5% -$26.2K ﹤0.01% 2657
2016
Q3 		$637K Sell
46,000
-3,300
-7% -$37.4K ﹤0.01% 2603
2016
Q2 		$487K Sell
49,300
-1,600
-3% -$26.5K ﹤0.01% 2732
2016
Q1 		$861K Sell
50,900
-3,100
-6% -$49.9K ﹤0.01% 2435
2015
Q4 		$1.2M Sell
54,000
-10,100
-16% -$255K ﹤0.01% 2270
2015
Q3 		$1.51M Hold
64,100
– – ﹤0.01% 2105
2015
Q2 		$5.24M Buy
64,100
+30,553
+91% +$2.99M 0.01% 1359
2015
Q1 		$1.58M Hold
33,547
– – ﹤0.01% 2282
2014
Q4 		$1.58M Buy
33,547
+5,331
+19% +$163K ﹤0.01% 2282
2014
Q3 		$690K Buy
28,216
+4,116
+17% +$65.4K ﹤0.01% 2751
2014
Q2 		$382K Buy
+24,100
New +$348K ﹤0.01% 3129

Other funds holding ESPR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

California Public Employees Retirement System's ESPR Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Esperion Therapeutics (ESPR) in Q2 2021, closing a stake of 52,800 shares — an estimated $1.48M sold.

California Public Employees Retirement System first reported a position in ESPR in Q2 2014 and held it in 28 quarters. The position peaked at $5.24M in Q2 2015. 142 funds tracked by Wall St. Rank hold ESPR as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Esperion Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 52,800 Esperion Therapeutics shares in Q2 2021, an estimated $1.48M.
  • California Public Employees Retirement System first reported a position in Esperion Therapeutics in Q2 2014 and held it in 28 quarters.
  • California Public Employees Retirement System's Esperion Therapeutics position peaked at $5.24M in Q2 2015.
  • 142 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.